Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy

J Nanobiotechnology. 2023 Nov 18;21(1):433. doi: 10.1186/s12951-023-02199-1.

Seyed Hossein Kiaie^{1

2}, Hossein Salehi-Shadkami^{3

4}, Mohammad Javad Sanaei⁵, Marzieh Azizi⁶, Mahdieh Shokrollahi Barough⁷, Mohammad Sadegh Nasr⁸, Mohammad Sheibani^{9

10}

¹ Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran. hosseinkiaie@gmail.com.
² Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. hosseinkiaie@gmail.com.
³ Department of Formulation Development, ReNAP Therapeutics, Tehran, Iran.
⁴ Department of Medical Science, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, 8815713471, Iran.
⁶ Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
⁷ Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran.
⁸ Department of Computer Science and Engineering Multi-Interprofessional Center for Health Informatics (MICHI), The University of Texas at Arlington, Arlington, TX, USA.
⁹ Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Mohammad.sheibani89@gmail.com.
¹⁰ Razi Drug Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Mohammad.sheibani89@gmail.com.

No abstract available

Publication types